Brief: Vivesto Reports Positive Interim Results For Paccal Vet Pilot Study In Dogs
07/11/2025 14:19
Nov 7 (Reuters) - Vivesto AB VIVE.ST: REPORTS POSITIVE INTERIM RESULTS FOR PACCAL VET PILOT STUDY IN DOGS PACAL VET TREATMENT EXTENDS SURVIVAL IN DOGS WITH HEMANGIOSARCOMA PIVOTAL STUDY PLANNED IF POSITIVE RESULTS CONFIRMED Source text: ID:nMFN6ZsyHP Further company coverage: VIVE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO